Seres Therapeutics Inc at Goldman Sachs Healthcare Conference Transcript
Welcome, everybody. Thank you for joining us at the Goldman Sachs 44th Annual Healthcare Conference. And we're very pleased to wrap up our first day of the event here with folks from Seres; CEO, Eric Shaff; Terri Young, Chief Commercialization Officer. And I'm here together with my colleague, Stephen, who is going to help me do this discussion. We are really at so many interesting points with your company, but really probably speaking the microbiome space.
Questions & Answers
Eric, you and I go back many, many years in terms of thinking about how we're going to take this concept (inaudible) right? And get it to become sort of pharmaceuticalize? Is that a word? We'll see what the transcript shows up when I say that, right? Just understanding that this is like literally century of thoughtfulness, documentation science, et cetera, that we're navigating.
So pharmaceuticalize might not
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |